{"doc_key": "sents_AND_True", "dataset": "ace-event", "sentences": [["There", "is", "further", "research", "to", "be", "done", "to", "improve", "both", "versions", "of", "the", "method", "including", "testing", "the", "effects", "of", "taphonomy", ",", "pathology", ",", "and", "fragmentation", "on", "the", "process", ",", "as", "well", "as", "expanding", "the", "method", "to", "other", "paired", "bones", ",", "reducing", "the", "overall", "cost", ",", "and", "fine-tuning", "the", "automated", "comparison", "algorithms", "."], ["Many", "aspects", ",", "host", "sociality", "for", "example", ",", "remain", "unexplored", ",", "but", "could", "prove", "highly", "important", "in", "the", "propensity", "for", "disease", "transmission", "Hayman", "et", "al.", "2013", "Luis", "et", "al.", "2013", "."], ["Future", "studies", "can", "better", "assess", "this", "by", "treating", "patients", "neoadjuvantly", "before", "surgery", "with", "genotoxic", "agents", "and", "staining", "biopsy", "samples", "for", "induced", "pSer784-VCP", "to", "correlate", "with", "short-term", "neoadjuvant", "tumor", "response", "and", "long-term", "survival", "during", "or", "after", "adjuvant", "treatment", "."], ["Furthermore", ",", "we", "plan", "to", "apply", "our", "technique", "in", "real-world", "scenarios", ",", "such", "as", "auditing", ",", "in", "which", "multi-range", "filtering", "may", "unveil", "possible", "pattern", "of", "fraud", "or", "non-compliance", "."], ["Facing", "a", "sharp", "decline", "in", "revenue", ",", "many", "hospitals", "have", "initiated", "layoffs", ",", "furloughs", ",", "and", "salary", "cuts", "to", "contain", "costs", "and", "maintain", "financial", "viability.3", "A", "detailed", "analysis", "of", "hospital", "cost", "structure", "remains", "an", "unexplored", "area", "in", "the", "literature", "."], ["Eichbaum", "et", "al.", "2004", "observed", "a", "possible", "trend", "for", "certain", "unfavorable", "prognostic", "parameters", "e.g.", ",", "young", "women", ",", "low-graded", "tumors", ",", "human", "epidermal", "growth", "factor", "receptor", "2", "over-expression", "that", "could", "be", "related", "to", "higher", "serum", "levels", "of", "sE-selectin", "."], ["In", "addition", ",", "tackling", "the", "systemic", "prothrombotic", "complication", "using", "anti-inflammatory", "medications", "such", "as", "anti-IL6R", "tocilizumab", "or", "sarilumab", ",", "or", "the", "anti-IL6", "antibody", "siltuximab", "or", "complement", "inhibiting", "strategies", "to", "prevent", "macro-", "and", "microthrombi", "represents", "another", "potential", "approach", "and", "several", "trials", "are", "currently", "verifying", "this", "hypothesis", "54", "."], ["As", "such", ",", "this", "issue", "continues", "to", "be", "an", "open", "diagnostic", "problem", "that", "affects", "both", "patients", "and", "health", "care", "professionals", "."], ["Therefore", ",", "we", "hypothesized", "that", "the", "presence", "of", "the", "turn", "might", "transform", "the", "secondary", "structure", "of", "the", "segment", "and", "cause", "the", "catalytic", "distinction", "of", "the", "two", "proteases", "."], ["Future", "works", "investigating", "the", "in", "vivo", "role", "of", "these", "interfering", "Ab", "subpopulations", "in", "HCV", "persistence", "will", "certainly", "be", "very", "useful", "."], ["MMPs", "have", "also", "been", "broadly", "implicated", "in", "several", "cardiovascular", "diseases", ",", "including", "atherosclerosis", "Libby", "2002", ",", "Galis", "and", "Khatri", "2002", ",", "aortic", "aneurysms", "Pyo", "et", "al.", "2000", ",", "and", "heart", "failure", "Lee", "and", "Libby", "2000", "and", ",", "therefore", ",", "may", "represent", "a", "relevant", "target", "for", "cardiovascular", "molecular", "imaging", "."], ["The", "49", "nucleotide", "deletion", "at", "245294", "bp", "is", "thought", "to", "be", "a", "marker", "of", "cellular", "adaptation", ",", "because", "most", "cell-adapted", "strains", "contain", "these", "deletions", ",", "but", "the", "evaluation", "of", "ORF3", "slightly", "changed", "strains", "on", "cell", "culture", "need", "to", "be", "further", "investigated", "."], ["In", "these", "patients", ",", "the", "histologic", "appearance", "of", "the", "brain", "biopsy", "confirmed", "an", "acute", "necrotizing", "pattern", "of", "vasculitis", "and", "may", "indicate", "related", "pathologic", "mechanisms", "to", "SARS-CoV-2", "24,25,28", "."], ["Follow-up", "analyses", "were", "conducted", "to", "explore", "whether", "any", "observed", "associations", "between", "antenatal", "risk", "and", "kindergarten", "readiness", "were", "attributable", "to", "a", "particular", "class", "of", "complications", "."], ["In", "conclusion", ",", "this", "study", "lends", "new", "insight", "into", "the", "role", "of", "HRV", "with", "respect", "to", "species-specific", "patterns", "of", "clinical", "symptom", "patterns", "and", "viral", "shedding", "in", "otherwise", "healthy", "children", "and", "adults", "with", "ILI", "."], ["The", "structural", "basis", "for", "nucleotide", "incorporation", "fidelity", "remains", "an", "open", "question", "for", "all", "nucleic", "acid", "polymerases", "."], ["The", "M2", "is", "thought", "to", "function", "as", "an", "ion", "channel", "that", "permits", "protons", "to", "enter", "virus", "particles", "during", "uncoating", "of", "virions", "in", "endosomes", "Pinto", "et", "al.", "1992", "."], ["Taken", "together", ",", "the", "microarray", "data", "suggest", "that", "Mtb", "infection", "significantly", "affects", "the", "expression", "of", "thousands", "of", "host", "genes", "in", "the", "lungs", "."], ["Lenalidomide", ",", "bortezomib", ",", "and", "thalidomide", "as", "single", "agents", ",", "or", "in", "combinations", ",", "have", "demonstrated", "improvements", "in", "PFS", "and", "OS", "in", "select", "multiple", "myeloma", "patients", "following", "autologous", "SCT", "1622", "however", ",", "the", "literature", "pertaining", "to", "the", "role", "of", "maintenance", "therapy", "following", "allogeneic", "SCT", "is", "scant", "."], ["However", ",", "evidence", "points", "to", "a", "collective", "interfering", "activity", "consistent", "with", "previous", "findings", ",", "based", "on", "fitness", "differences", "between", "entire", "viral", "populations", "and", "their", "component", "biological", "clones", "Domingo", "et", "al.", ",", "1978", ",", "Duarte", "et", "al.", ",", "1994", ",", "of", "the", "collective", "behavior", "of", "mutant", "spectra", "."], ["However", ",", "this", "should", "be", "investigated", "in", "an", "extensive", "cost-effectiveness", "study", "."], ["These", "findings", "may", "indicate", "that", "those", "affinities", "between", "CsA", "and", "Cyps", "affect", "FCoV", "replication", "."], ["Of", "significant", "note", "is", "that", "antibiotic", "treatment", "results", "in", "resolution", "of", "clinical", "signs", "but", "may", "not", "result", "in", "elimination", "of", "the", "organism", "."], ["Future", "research", "may", "also", "focus", "on", "examining", "whether", "the", "moderating", "effects", "of", "psychological", "inflexibility", ",", "intolerance", "of", "uncertainty", ",", "and", "emotional", "suppression", "on", "social", "isolation", "and", "mental", "health", "functioning", "are", "observed", "under", "experimental", "conditions", ",", "thus", "providing", "more", "information", "on", "the", "causal", "relationships", "between", "these", "variables", "."], ["In", "general", ",", "RIG-I", "signaling", "leads", "to", "both", "type", "I", "and", "type", "III", "interferon", "gene", "induction", ",", "but", "how", "this", "predominant", "induction", "of", "type", "III", "interferons", "during", "HBV", "infection", "occurs", "remains", "to", "be", "clarified", "."], ["While", "increased", "CXCL17", "expression", "is", "associated", "with", "disease", "progression", "in", "pulmonary", "fibrosis", ",", "asthma", ",", "and", "lunghepatic", "cancer", ",", "it", "is", "thought", "to", "play", "a", "protective", "role", "in", "pancreatic", "cancer", ",", "autoimmune", "encephalomyelitis", "and", "viral", "infections", "."], ["Previous", "studies", "in", "Japan", "showed", "that", "mild", "encephalitisencephalopathy", "with", "a", "reversible", "splenial", "lesion", "MERS", "could", "be", "triggered", "by", "adenovirus", "infection", "26", ",", "27", ",", "which", "was", "proposed", "to", "be", "caused", "by", "neurotoxins", ",", "likely", "acting", "as", "an", "antigen", "that", "induced", "a", "strong", "immune", "response", ",", "leading", "to", "a", "series", "of", "symptoms", "."], ["Moreover", ",", "it", "has", "been", "speculated", "that", ",", "even", "when", "not", "directly", "interfering", "with", "nAbs", "binding", ",", "non-nAbs", "may", "also", "lead", "to", "the", "enhancement", "of", "viral", "infection", "through", "interaction", "with", "Fc", "receptors", "or", "complement", "receptors", "17", "."], ["Studies", "suggest", "that", "early", "erythrocyte", "transfusions", "are", "associated", "with", "an", "increased", "risk", "of", "severe", "IVH", ",", "ROP", "and", "mortality", "2830", "."], ["The", "routine", "use", "of", "simple", "infection", "prevention", "practices", "can", "likely", "dramatically", "reduce", "HAIs", "."], ["These", "results", "support", "the", "hypothesis", "that", "APRV", "may", "offer", "potential", "clinical", "advantages", "for", "ventilatory", "management", "and", "may", "be", "considered", "as", "an", "alternative", "rescue", "mechanical", "ventilation", "mode", "in", "pediatric", "ARDS", "patients", "refractory", "to", "conventional", "ventilation", "."], ["The", "persistence", "of", "high", "pulmonary", "blood", "flow", "to", "non-aerated", "lung", "alveoli", "appears", "to", "be", "caused", "by", "the", "relative", "failure", "of", "the", "hypoxic", "pulmonary", "vasoconstriction", "mechanism", "constriction", "of", "small", "intrapulmonary", "arteries", "in", "response", "to", "alveolar", "hypoxia", "during", "SARS-CoV-2", "infection", ",", "as", "recently", "illustrated", "by", "Lang", "et", "al.", "using", "dual-energy", "CT", "42", ",", "43", "."], ["Further", "work", "is", "urgently", "needed", "to", "determine", "the", "impact", "of", "decontamination", "technologies", "on", "respirator", "function", "."], ["Thus", ",", "we", "can", "utilize", "our", "identified", "APPs", "as", "markers", "to", "predict", "active", "TB", "and", "other", "inflammatory", "diseases", ",", "but", "further", "studies", "and", "including", "active", "TB", "and", "other", "inflammatory", "diseases", "into", "the", "studies", "are", "needed", "to", "confirm", "this", "prediction", "."], ["While", "the", "present", "study", "adds", "to", "the", "existing", "body", "of", "knowledge", "in", "the", "perceived", "risk", "associated", "with", "online", "transactions", "by", "examining", "the", "given", "model", "between", "the", "online", "customers", "considering", "an", "emerging", "economy", ",", "several", "limitations", "are", "present", "that", "remain", "to", "be", "addressed", "and", "creates", "an", "avenue", "for", "future", "research", "."], ["Future", "studies", "should", "also", "investigate", "how", "age-related", "differences", "affect", "SARS-CoV-2", "actions", "in", "the", "OE", "."], ["The", "exponentially", "spreading", "pandemic", "of", "COVID-19", "deserves", "prime", "public", "health", "attention", "to", "evaluate", "yet", "unexplored", "arenas", "of", "management", "."], ["Thus", "in", "our", "murine", "model", ",", "quantification", "of", "viremia", ",", "virus", "load", "and", "examining", "histopathologic", "changes", "are", "necessary", "to", "further", "investigate", "the", "antiviral", "efficacy", "of", "CPMO1v", "."], ["Currently", ",", "there", "is", "no", "specific", "anti-viral", "therapy", "or", "vaccine", "available", "for", "COVID-19", "."], ["Other", "signaling", "pathways", "could", "be", "evaluated", "using", "the", "same", "methodology", "."]], "predicted_ner": [[], [[79, 79, "GPE", 3.9037, 0.9802]], [[91, 91, "PER", 25.6601, 1.0], [97, 97, "WEA", 12.6683, 1.0]], [], [[158, 158, "ORG", 32.8647, 1.0], [179, 179, "FAC", 31.5978, 1.0]], [[190, 190, "PER", 15.4232, 1.0], [206, 206, "PER", 28.1196, 1.0], [211, 211, "PER", 14.574, 1.0]], [[267, 267, "PER", 5.6771, 0.9966]], [[290, 290, "PER", 45.0296, 1.0], [294, 294, "PER", 49.1274, 1.0]], [], [[334, 334, "LOC", 15.5923, 1.0], [335, 335, "GPE", 14.8357, 1.0], [337, 337, "GPE", 12.1663, 1.0]], [[361, 361, "PER", 7.0137, 0.9991], [363, 363, "PER", 11.9927, 1.0], [376, 376, "PER", 1.3092, 0.7874]], [[414, 414, "PER", 8.6228, 0.9998], [428, 428, "ORG", 3.2647, 0.6318]], [[438, 438, "PER", 34.0614, 1.0]], [], [[501, 501, "PER", 9.7638, 0.7979], [517, 517, "PER", 17.7821, 1.0], [519, 519, "PER", 26.9612, 1.0]], [[529, 529, "ORG", 24.5674, 1.0], [538, 538, "ORG", 12.4356, 1.0]], [[541, 541, "WEA", 2.3801, 0.9052], [552, 552, "PER", 17.1323, 1.0]], [], [[591, 591, "PER", 15.8544, 1.0], [593, 593, "PER", 9.8267, 0.9999], [596, 596, "PER", 14.9114, 1.0], [599, 599, "PER", 13.8662, 1.0], [616, 616, "PER", 16.2776, 1.0]], [[659, 659, "GPE", 21.4928, 1.0]], [], [], [[733, 733, "ORG", 20.1729, 1.0]], [], [], [], [[857, 857, "GPE", 23.7935, 1.0]], [], [], [], [[1007, 1007, "PER", 25.7402, 1.0]], [[1056, 1056, "GPE", 8.7685, 0.9992], [1057, 1057, "GPE", 4.6639, 0.9568]], [[1079, 1079, "PER", 33.977, 1.0]], [[1114, 1114, "PER", 6.6731, 0.9987]], [[1149, 1149, "PER", 24.7537, 1.0]], [], [], [], [], []], "predicted_relations": [[], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], []], "predicted_events": [[], [], [], [], [[[161, "Personnel.End-Position", 19.3537, 1.0]]], [], [[[267, "Justice.Trial-Hearing", 3.2262, 0.9618]]], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], []]}
